JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267318

Human CCND2 (Cyclin D2) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(1 Publication)

CCND2 KO cell line available to order. KO validated by Western blot. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 8 bp insertion in exon 1.

View Alternative Names

CCND2_HUMAN, CyclinD2, G1/S-specific cyclin-D2, KIAK0002, MGC102758, MPPH3

3 Images
Western blot - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (AB267318)
  • WB

Lab

Western blot - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (AB267318)

All lanes:

Western blot - Anti-Cyclin D2 antibody [EPR19659] (<a href='/en-us/products/primary-antibodies/cyclin-d2-antibody-epr19659-ab207604'>ab207604</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human CCND2 (Cyclin D2) knockout HEK-293T cell lysate (<a href='/en-us/products/cell-lysates/human-ccnd2-cyclin-d2-knockout-hek-293t-cell-lysate-ab257875'>ab257875</a>) at 20 µg

Lane 2:

Western blot - Human CCND2 (Cyclin D2) knockout HEK-293T cell lysate (<a href='/en-us/products/cell-lysates/human-ccnd2-cyclin-d2-knockout-hek-293t-cell-lysate-ab257875'>ab257875</a>)

Lane 2:

Western blot - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (ab267318)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

U-2 OS cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Lanes 1 - 4:

Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution

Predicted band size: 33 kDa

Observed band size: 33 kDa

false

Sanger Sequencing - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (AB267318)
  • Sanger seq

Unknown

Sanger Sequencing - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (AB267318)

Allele-1 : 2 bp deletion in exon1

Sanger Sequencing - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (AB267318)
  • Sanger seq

Unknown

Sanger Sequencing - Human CCND2 (Cyclin D2) knockout HEK-293T cell line (AB267318)

Allele-2 : 8 bp insertion in exon 1.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 8 bp insertion in exon 1

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267318-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267318 Human CCND2 (Cyclin D2) knockout HEK-293T cell line", "number":"AB267318-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267318-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267318 Human CCND2 (Cyclin D2) knockout HEK-293T cell line", "number":"AB267318-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
CCND2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Journal of oncology 2022:5456016 PubMed36164345

2022

miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yeru Tan,Yuehua Li,Hongbo Zhu,Xiaoping Wu,Kai Mei,Pian Li,Qiao Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com